Erratum: Symptomatic lipid storage in carriers for the PNPLA2 gene (European Journal of Human Genetics (2013) 21 (807-815) DOI: 10.1038/ejhg.2012.256);Symptomatic lipid storage in carriers for the PNPLA2 gene

European Journal of Human Genetics

Volumn 21, Issue 8, 2013, Pages 807-815

  Janssen, Mirian C H ^a   Van Engelen, Baziel ^a,b   Kapusta, Livia ^a,c   Lammens, Martin ^a,d   Van Dijk, Martin ^a   Fischer, Judith ^e   Van Der Graaf, Marinette ^a   Wevers, Ron A ^a,d   Fahrleitner, Manuela ^b   Zimmermann, Robert ^b   Morava, Eva ^a,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRAZ   (Austria)

^c WOLFSON MEDICAL CENTER   (Israel)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Deafness; Implantable cardioverter defibrillator; Insulin resistance; Lipid myopathy; Neutral lipid storage; Symptomatic carriers

Indexed keywords

CARRIER PROTEIN; CREATINE KINASE; FAT DROPLET; PNPLA 2 PROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CHEMICAL ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORNEA CELL; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID STORAGE; LIPIDOSIS; MALE; MUSCLE; MUSCLE BIOPSY; MYOPATHY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WILD TYPE;

EID: 84880919361     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.11     Document Type: Erratum

References (27)

1. Chanarin I, Patel A, Wills EJ, Andrews TM, Stewart G: Neutral lipid storage disease: A new disorder of lipid metabolism. Br Med J 1975; 1: 553-555
2. Radom J, Salvayre R, Negre A, Maret A, Douste-Blazy L: Metabolism of neutral lipids in cultured fibroblasts from multisystemic (or type 3) lipid storage myopathy. Eur J Biochem 1987; 164: 703-708
3. Jordans GH: The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva (ERB). Acta Med Scand 1953; 145: 419-423
4. Fischer J, Lefevre C, Morava E et al: The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 2007; 39: 28-30
5. Chen J, Hong D, Wang Z, Yuan Y: A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles. Clin Neuropathol 2010; 29: 351-356
6. Lefevre C, Jobard F, Caux F et al: Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 2001; 69: 1002-1012
7. Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G: Triglyceride deposit cardiomyovasculopathy. N Engl J Med 2008; 359: 2396-2398
8. Akiyama M, Sawamura D, Nomura Y, Sugawara M, Shimizu H: Truncation of CGI-58 protein causes malformation of lamellar granules resulting in ichthyosis in Dorfman-Chanarin syndrome. J Invest Dermatol 2003; 121: 1029-1034
9. Campagna F, Nanni L, Quagliarini F et al: Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy. Biochem Biophys Res Commun 2008; 377: 843-846
10. Kobayashi K, Inoguchi T, Maeda Y et al: The lack of the C-Terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab 2008; 93: 2877-2884
11. Akman HO, Davidzon G, Tanji K et al: Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene. Neuromuscul Disord 2010; 20: 397-402
12. Reilich P, Horvath R, Krause S et al: The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene. J Neurol 2011; 258: 1987-1997
13. Schweiger M, Schoiswohl G, Lass A et al: The C-Terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding. J Biol Chem2008; 283: 17211-17220
14. Akiyama M, Sakai K, Ogawa M, McMillan JR, Sawamura D, Shimizu H: Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. Muscle Nerve 2007; 36: 856-859
15. Ohkuma A, Nonaka I, Malicdan MC et al: Distal lipid storage myopathy due to PNPLA2 mutation. Neuromuscul Disord 2008; 18: 671-674
16. Lass A, Zimmermann R, Haemmerle G et al: Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 2006; 3: 309-319
17. Smirnova E, Goldberg EB, Makarova KS, Lin L, Brown WJ, Jackson CL: ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells. EMBO Rep 2006; 7: 106-113
18. Coassin S, Schweiger M, Kloss-Brandstä tter A et al: Investigation and functional characterization of rare genetic variants in the adipose triglyceride lipase in a large healthy working population. PLoS Genet 2009; 6: E1001239
19. Grönke S, Mildner A, Fellert S et al: Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila. Cell Metab 2005; 1: 323-330
20. Kurat CF, Natter K, Petschnigg J et al: Obese yeast: Triglyceride lipolysis is functionally conserved from mammals to yeast. J Biol Chem 2006; 281: 491-500
21. Villena JA, Roy S, Sarkady-Nagy E, Kim KH, Sul HS: Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: Ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 2004; 279: 47066-47075
22. Zechner R, Strauss JG, Haemmerle G, Lass A, Zimmermann R: Lipolysis: Pathway under construction. Curr Opin Lipidol 2005; 16: 333-340
23. Tack CJ, Ong MK, Lutterman JA, Smits P: Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 1998; 41: 569-576
24. Demerjian M, Crumrine DA, Milstone LM, Williams ML, Elias PM: Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Chanarin-Dorfman Syndrome). J Invest Dermatol 2006; 126: 2032-2038
25. Cornaciu I, Boeszoermenyi A, Lindermuth H et al: The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively. PLoS One 2011; 6: E26349
26. Haemmerle G, Lass A, Zimmermann R et al: Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-737
27. Haemmerle G, Moustafa T, Woelkart G et al: ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-A and PGC-1. Nat Med 2011; 17: 1076-1085